PRTG Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 May 2024 @ 16:00):

Stats
Today's Volume	283 941
Average Volume	170 844
Market Cap	5.28M
EPS	$0 ( 2024-05-14 )
Next earnings date	( $-0.220 ) 2024-07-29
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0300
ATR14	$0.00600 (2.25%)

Volume Correlation

Long: -0.25 (neutral)

Short: 0.92 (very strong)

Signal:(61.149) Expect same movement, but be aware

Portage Biotech Inc. Correlation

10 Most Positive Correlations
FFIE	0.952
EVOK	0.943
NWFL	0.941
GLBS	0.941
IMMX	0.938
MNSB	0.937
BPRN	0.937
INVZ	0.937
EBIX	0.936
VVOS	0.934

10 Most Negative Correlations
FTIV	-0.938
KVSC	-0.934
NVCN	-0.923
TETC	-0.922
SPLK	-0.919
APXI	-0.916
ROVR	-0.914
VLAT	-0.914
ADAL	-0.912
ADTH	-0.912

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Portage Biotech Inc. Correlation - Currency/Commodity

-0.28
( neutral )

-0.47
( neutral )

0.00
( neutral )

0.18
( neutral )

Portage Biotech Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-1 000.00 (0.00 %)
EPS:	$-6.49

FY	2023
Revenue:	$0
Gross Profit:	$-1 000.00 (0.00 %)
EPS:	$-6.49

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-1.470

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.350

Financial Reports:

No articles found.

Portage Biotech Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Portage Biotech Inc.

Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.